Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Combination of Gardenia jasminoides, Boswellia serrata, Commiphora myrrha, Foeniculum vulgarae, and Daucus carota Essential Oil Blend Improved the Inflammatory and Clinical Status in Respiratory Tract Infection of COVID-19 Patients: A Multicentre, Randomized, Open-label, Controlled Trial

The Indonesian Biomedical Journal · Vol. 16 No. 3 (2024) · hlm. 237–247

DOI
10.18585/inabj.v16i3.3023
ISSN
2085-3297, 2355-9179
Terbit
2024-06-26
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Essential oils (EO) are complex volatile, naturally synthesized compounds from aromatic plants. It considers as healthy, effective, and safe since they were coming from nature. Gardenia jasminoides, Boswellia serrata, Commiphora myrrha, Foeniculum vulgarae, and Daucus carota are known to have antimicrobials, antioxidants, antiinflammation properties against respiratory tract infection. However, despite its natural content, a safety profile needs to be observed. Therefore, in this study, EO blend (EOB) made from the combination of these 5 plants was assessed for its efficacy and safety for respiratory tract infection in human.METHODS: A multicentre, randomized, open-label, phase II controlled trial involving 80 hospitalized adults with COVID-19 was conducted. One group of subjects only received standard of care (SoC), while the other group receive SoC and EOB orally for 10 days.RESULTS: There were significant decrease in interleukin (IL)-6 level (p=0.016) and interferon (IFN)-γ level (p=0.012), as well as better respiratory rate (p=0.024) for the group receiving SoC and EOB compared to the group receiving SoC only. However, there was no significant differences in aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, and the corrected QT interval (QTc) prolongation value in both groups. All subjects with adverse effects were improved and recovered, and there were no serious adverse events found.CONCLUSION: The combination of G. jasminoides, B. serrata, C. myrrha, F. vulgarae, and D. carota EOB could improve the inflammatory and clinical status and safe to be used as adjuvant therapy for treating COVID-19 in adults.KEYWORDS: essential oils, COVID-19, inflammation, safety

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 158 tautan kepenulisan bersama · 80 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Hasanuddin University
  • Dr. Hasan Sadikin General Hospital
  • PT Prodia StemCell Indonesia (Indonesia)
  • University of Indonesia
  • Udayana University
  • Diponegoro University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University91
Nurrani Mustika DewiPadjadjaran University45
Melisa Intan BarlianaPadjadjaran University6
Irma Rahayu LatarissaPadjadjaran University5
Suryani As’ádHasanuddin University3
Irma Ruslina DefiPadjadjaran University2
Anwar SantosoUdayana University2
Ilhamjaya PatellongiHasanuddin University2
Ahmad FariedPadjadjaran University2
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)2
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)2
Rina TrianaPadjadjaran University2
Syarifah InayatiInstitut Teknologi Sepuluh Nopember1
Hasbi YasinDiponegoro University1
Ni Luh Putu Inca Buntari AgustiniInstitut Teknologi dan Kesehatan Bali1
Nursalam NursalamUniversitas Airlangga1
Diah PriyantiniUniversitas Muhammadiyah Surabaya1
Elsi Dwi HapsariUniversitas Gadjah Mada1
Khatijah Lim AbdullahSunway University1
Emmy Hermiyanti PranggonoPadjadjaran University1
Endah Nurul AiniDr. Hasan Sadikin General Hospital1
Uun SumardiDr. Hasan Sadikin General Hospital1
Adhi Kristianto SugianliDr. Hasan Sadikin General Hospital1
Kusman IbrahimPadjadjaran University1
Sidik MaulanaPadjadjaran University1
Iqbal PramuktiPadjadjaran University1
Shakira AmirahRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The Combination of Gardenia jasminoides, Boswellia serrata, Commiphora myrrha, Foeniculum vulgarae, and Daucus carota Essential Oil Blend Improved the Inflammatory and Clinical Status in Respiratory Tract Infection of COVID-19 Patients: A Multicentre, Randomized, Open-label, Controlled Trial</dc:title><dc:creator>Keri Lestari</dc:creator><dc:creator>Haig Yousef Babikian</dc:creator><dc:creator>Iceu Dimas Kulsum</dc:creator><dc:creator>Ferdy Ferdian</dc:creator><dc:creator>Efriadi Ismail</dc:creator><dc:creator>Yelsen Sumalim</dc:creator><dc:creator>Setiawan Setiawan</dc:creator><dc:creator>Prayudi Santoso</dc:creator><dc:creator>Yovita Hartantri</dc:creator><dc:creator>Arief Riadi Arifin</dc:creator><dc:creator>Anna Meiliana</dc:creator><dc:creator>Ida Paulina Sormin</dc:creator><dc:creator>Erizal Sugiono</dc:creator><dc:subject>essential oil blends</dc:subject><dc:subject>Gardenia jasminoides</dc:subject><dc:subject>Boswellia serrata</dc:subject><dc:subject>Commiphora myrrha</dc:subject><dc:subject>fennel</dc:subject><dc:subject>carrot</dc:subject><dc:subject>COVID-19 pandemic</dc:subject><dc:subject>respiratory infections</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>interleukin-6</dc:subject><dc:subject>interferon-gamma</dc:subject><dc:subject>respiratory rate</dc:subject><dc:subject>safety</dc:subject><dc:subject>adjuvant therapy</dc:subject><dc:description xml:lang="en">BACKGROUND: Essential oils (EO) are complex volatile, naturally synthesized compounds from aromatic plants. It considers as healthy, effective, and safe since they were coming from nature. Gardenia jasminoides, Boswellia serrata, Commiphora myrrha, Foeniculum vulgarae, and Daucus carota are known to have antimicrobials, antioxidants, antiinflammation properties against respiratory tract infection. However, despite its natural content, a safety profile needs to be observed. Therefore, in this study, EO blend (EOB) made from the combination of these 5 plants was assessed for its efficacy and safety for respiratory tract infection in human.METHODS: A multicentre, randomized, open-label, phase II controlled trial involving 80 hospitalized adults with COVID-19 was conducted. One group of subjects only received standard of care (SoC), while the other group receive SoC and EOB orally for 10 days.RESULTS: There were significant decrease in interleukin (IL)-6 level (p=0.016) and interferon (IFN)-γ level (p=0.012), as well as better respiratory rate (p=0.024) for the group receiving SoC and EOB compared to the group receiving SoC only. However, there was no significant differences in aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, and the corrected QT interval (QTc) prolongation value in both groups. All subjects with adverse effects were improved and recovered, and there were no serious adverse events found.CONCLUSION: The combination of G. jasminoides, B. serrata, C. myrrha, F. vulgarae, and D. carota EOB could improve the inflammatory and clinical status and safe to be used as adjuvant therapy for treating COVID-19 in adults.KEYWORDS: essential oils, COVID-19, inflammation, safety</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-06-26</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v16i3.3023</dc:identifier><dc:identifier>10.18585/inabj.v16i3.3023</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 3 (2024); 237-247</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3023/712</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>